Actieve functies van Brian Sun
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TURG POIN | Algemeen Adviseur | 11-04-2022 | - |
Loopbaan van Brian Sun
Eerdere bekende functies van Brian Sun
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Algemeen Adviseur | - | - |
| Bedrijfssecretaris | - | - |
Opleiding van Brian Sun
| University of San Diego | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| General Counsel | 2 |
| Graduate Degree | 2 |
| Corporate Secretary | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
